Cite
High expression of HOXA4 in patients with glioma indicates unfavorable clinical outcomes.
MLA
Yu, Zhenghong, et al. “High Expression of HOXA4 in Patients with Glioma Indicates Unfavorable Clinical Outcomes.” Cell Cycle, vol. 21, no. 22, Nov. 2022, pp. 2387–402. EBSCOhost, https://doi.org/10.1080/15384101.2022.2096715.
APA
Yu, Z., Liu, Z., Lian, X., Cheng, X., Liu, B., Zhang, B., Wang, H., Wang, J., Li, A., Ren, Z., Pang, B., Qian, R., & Gao, Y. (2022). High expression of HOXA4 in patients with glioma indicates unfavorable clinical outcomes. Cell Cycle, 21(22), 2387–2402. https://doi.org/10.1080/15384101.2022.2096715
Chicago
Yu, Zhenghong, Zhendong Liu, Xiaoyu Lian, Xingbo Cheng, Binfeng Liu, Bo Zhang, Hongbo Wang, et al. 2022. “High Expression of HOXA4 in Patients with Glioma Indicates Unfavorable Clinical Outcomes.” Cell Cycle 21 (22): 2387–2402. doi:10.1080/15384101.2022.2096715.